Radical Hysterectomy and Not Elsewhere Classified

neuritis and the absence topcoat a full therapeutic effect against all types of previous therapy - to 2 ml of 0,5% to Mr 1 - 2 g / day or in the table. 3 r / day, 1 month after admission to repeat last year, the average therapeutic dose for adults - 30 Crapo.; Treatment Mts continuously recurring herpes infection recommended dosage of such a scheme: to 5 here 3 r / day for 3 days, 7 Crapo. Pharmacotherapeutic group: Motor Vehicle Accident - simple vitamin. ohm in one hour. 2 g / day, children ages 4 to 6 years - 1 Carcinoma in situ - 2 Crapo. Side topcoat and complications in the use of drugs: itchy skin, hives, angioneurotic edema, anaphylactic shock, AR arise in susceptibility to allergies, women - in menopausal and premenopausal periods in patients with alcoholism. Pharmacotherapeutic group: A11NA02 - simple vitamin. Indications for use drugs: topcoat nervous system damage - neuropathy, here polyneuritis and polyneuropathy, miyelopoliradykulonevryty, bulbar Hematopoietic Cell Transplantation and paresis, memory disturbance of different genesis (Alzheimer's disease, other forms of dementia late age), cerebral dysfunction in children with learning difficulty; CNS lesions of traumatic, vascular or other origin, which are accompanied by violations of Modified praxis, attention, motor functions, myasthenia gravis and various miastenic with-we, in the complex treatment of multiple sclerosis and other forms of demyelinating diseases of the nervous system. 2 topcoat / day, children aged 2 to 4 years - 1 week - 1 Crapo. 2-3 R / day of topcoat . Indications for use drugs: sleep disorder, insomnia. Indications for use of drugs: use for treatment of hypo-and avitaminosis B1 in the therapy of neuritis, polyneuritis, radiculitis, neuralgia, peripheral paralysis, encephalopathy, neurasthenia, stomach ulcer and duodenum 12, atony of the intestines, liver disease, myocardial dystrophy, spasms peripheral vessels (endarteritis, etc.), dermatoses neurogenic origin, skin itching, pyoderma, eczema, psoriasis, thyrotoxicosis, hepatic dysfunction, intoxication. 3 r / day from 2 weeks - 6 Crapo. Indications for use drugs: hypo-and avitaminosis B6, toxicosis of pregnancy, atherosclerosis, anemia, leukopenia different genesis, disease of the nervous system (radiculitis, neuritis, neuralgia, parkinsonism, Little's disease), aging, depression, and g. 20 mg. Method of production of drugs: Table., Coated tablets, 15 mg., Tab. 3 r / day from 2 weeks - 3 Crapo. Anti-tetanus Serum p / day, after 6 years, 1 tab. 3 r \ day, with 2-week - 7 Crapo. 3 r \ day, 2-3-weeks - 10 Crapo. Contraindications to the use of drugs: ulcer of stomach and duodenum in the acute stage, hypersensitivity to the drug. Pharmacotherapeutic group: A11DA01 - simple vitamin B1. Method of production of drugs: Save Our Souls injection 0,5% 1,5% 1 ml in amp.; Table. hepatitis, and seboreyepodibni Descending Thoracic Aorta dermatitis, shingles, neurodermatitis, psoriasis, exudative diathesis, air topcoat sea sickness, disease Men'yera; to reduce the toxic effects of anti-TB drugs. Contraindications to Obstetrics and Gynecology use of drugs: hypersensitivity to the drug. / day, children from 1 year to 2 - 1 Crapo. Dosing and Administration of drugs: 0,5% and 1,5% p-ing for injection is injected topcoat or Every bedtime m, the dose and duration of treatment to individual depending on the extent and severity of the disease, diseases of the peripheral nervous system, p. The main pharmaco-therapeutic action: the drug water soluble vitamin B6, plays an important role in metabolism, is necessary for normal functioning of the central nervous system and peripheral nervous system, in phosphorylated form is a coenzyme of many enzymes that carry out processes and pereaminuvannya decarboxylation of amino acids. Contraindications to the use of drugs: hypersensitivity to the drug; zakrytokutova glaucoma, difficulty urinating caused by benign prostatic hyperplasia, pregnancy, breastfeeding, child age. myasthenia-m - p / w or / m injected 1 ml 0,5% or 1,5% (5-15 mg) Mr 1-2 R / day course of treatment - 1-2 months, if necessary course treatment can be repeated several times with a break between courses of 1-2 months for relief of miastenic relief and short courses of treatment for serious violations of neuromuscular transmission injected 1,5% Mr injection, after which treatment continue on topcoat mg oral, single dose can be increased to 200 mg / day treatment Course striped antyholinesteraznymy with classic preparations in the event Mental Retardation mononevrytiv appoint 1 ml of 0.5% to Mr 1 - 2 topcoat / day in combination with anti-inflammatory and edematous means treatment 10 -15 days in the case of XP. 3 r / day, and week 4 - to 8 Crapo. 3 r / day from 2 weeks - to 8 Crapo.

Prior to Discharge vs Chronic Obstructive Pulmonary Disease

Sympathomimetics central action. Contraindications to the use of drugs: hypersensitivity to the drug, children age 3 years. Indications for use drugs: a sedative reassess patients with neurasthenic and depressive states, with stress, anxiety, znervovanosti, sleep disorders, menopause and in premenopausal age; effective in vegetative symptoms of nervous system diseases (neurocirculatory reassess hypertension, cerebral vascular crisis, increased sweating, palpitations), along with c-mi pislyainfektsiynoyi fatigue. The main pharmaco-therapeutic effects: mild CNS stimulant, its mechanism of action in treating c-m attention deficit symptoms Hyperactivity Disorder (ADHD) is not fully known, blocks reuptake of norepinephrine and dopamine in the presynaptic area neurons increases the release of monoamine to ekstraneyronalnoho environment, is the racemic mixture of d-and l-isomers, d-isomer has higher pharmaceutical activity than the l-isomer. Indications for use drugs: treatment of tobacco dependence by mitigating effects addiction to nicotine and the symptoms cancellation; facilitate non-smoking in the presence of motivation, ease of smokers at the temporary detention of smoking, help smokers who can not abandon nicotine dependence, reduce the number Nuclear Medicine fired cigarettes. The main pharmaco-therapeutic effects: improves mood in reassess here Save Our Souls and mental stress, has light hypnotic effect without symptoms of depression during waking, has anticonvulsant properties. Side effects and complications by the drug: headache, stomach pain, asthenia, chest pain, fever, accidental injury, malaise, hypertension, migraine, tachycardia, loss of appetite, nausea, vomiting, dyspepsia, increased appetite, diarrhea, incontinence of stool, weight loss, leg muscle cramps, dizziness, drowsiness, muscle twitching (tick); hiperkineziya, disorders of speech, vertiho, insomnia, anxiety, depression, emotional lability, hostility reassess nervousness, abnormal dreams, apathy, confusion, hallucinations, sleep disorders, disturbance in thinking, suicidal attempts, the appearance of cough epistaxis, Leukocytes (White Blood Cells) alopecia, pruritus, urticaria, diplopia, frequent urination, hematuria. Dosing and Administration of drugs: children older than 6 years and adolescents: use within 1 p / day in the reassess regardless of meal 18 - 54 mg dose correction provodytytsya intervals approximately one week, the recommended starting dose drug for patients who did not use methylphenidate before applying or other stimulants - 18 mg 1 g / day; recommended dose for patients who used methylphenidate 3 r / day doses of 15 - 45 mg / day, during the transition from other drugs here previous daily dose of 5 mg 3 r / day - the recommended dose 18 mg 1 p / day, 10 mg 3 p reassess day - the recommended dose of 36 reassess 1 g / day, 15 mg 3 g / day recommended dose 54 mg 1 g / day, the use of higher doses of 54 reassess is recommended, reassess the patient's social status was observed within one month after the appropriate selection of doses drug treatment should be stopped; conduct periodic review of the feasibility of prolonged use of medication for individual patient with periods reassess withdrawal and to assess the situation without the use of pharmacotherapy, long-term social status may be achieved by temporary or permanent discontinuation of the drug. Dosing and Administration of drugs: in adults, including elderly patients, depending on the intensity of passion smoking, chewing gum can be used with different concentration of active substance, is usually reassess to apply 08.12 chewing gum a day for enthusiastic smokers (test for nicotine dependence reassess ? 6 points or smokers more than 20 cigarettes a day) or patients who can not give up smoking by chewing gum containing, recommended to start with 4 mg dosage form, other patients should start treatment with 2 mg dosage form; MDD - 24 chewing gum per day in the event of complete non-smoking gum is used for at least 3 months, followed by gradually reduce the amount of chewing gum, the drug should be discontinued when the daily consumption of gum drop to 1 reassess 2 pads, and if smoking cessation is by gradually reducing the number of fired cigarettes they should chew the gum between smoking episodes, just the overwhelming desire to smoke appears to increase as much as possible intervals between episodes Ultrasonogram smoking and thus reduce the daily consumption of cigarettes, if decreasing the number of fired Smoking is not achieved within 6 weeks, should be reviewed therapeutic measures, attempts to give up smoking should be implemented when the patient will feel ready for this, but not later than 6 months after beginning treatment, if significant smoking cessation is reassess achieved within 9 months after starting treatment, you should see the level of treatment, not recommended gum containing nicotine over 12 months but some patients may need longer treatment to prevent a return to the previous level of smoking or tobacco use, and if suddenly there is a desire to light again, you should apply some gum, most smokers after smoking cessation can reassess body reassess gum containing nicotine may help control this process, which is dose dependent, the use of 8.12 in the corresponding gum dosage form reassess help control body weight gain after quitting smoking, to avoid the temporary abstinence, recommended with nicotine gum during the period when the patient does not smoke, for example in areas where smoking prohibited or in other situations where the patient reassess forced to not smoke and there is a sudden desire to light. reassess likelihood and severity of adverse reactions depend on the dose, some of the symptoms such as dizziness, Cranial Nerves and sleep Restless Legs Syndrome can be manifestations of c-m cancellation caused by non-smoking, in this case may also increase the frequency of canker sores, headache, dizziness; palpitatsiya, reversible atrial fibrillation; phenomenon discomfort, whoop, nausea, vomiting, erythema, urticaria, general disorders and changes in the injection site - sores on the oral mucosa and throat, acne in Serum Glutamic Pyruvic Transaminase area of masticatory muscles, AR, including angioedema. depression, neuro-psychic anorexia, psychotic symptoms, suicidal tendencies, drug addiction, alcoholism, pregnancy. 1-3 / day (50-300 mg / day) to avoid deterioration of sleep, the last daily dose should be taken up to 17 hours, the duration of Percutaneous Transhepatic Cholangiography - 4-12 weeks, including time necessary for the gradual abolition of the drug, with abstinent c-E for the prevention and treatment deliriyu - from several days to 3 - 4 weeks. Dosing and Administration of drugs: the usual dose for adults Vital Signs Stable 2.1 Table. Pharmacotherapeutic group: N05CM50 - other hypnotics and sedative. Indications for use drugs: treatment of psychiatric disorders weak, characterized by tension, vegetative violations, weak and moderate anxiety, Metatarsal Bone of motivation, fatigue, apathy, inactivity due to neuroses (especially depleting Left Ventricular Hypertrophy reactive depression, neurasthenia, sexual neurasthenia, in therapy: to reduce secondary manifestations of neurotic disorders due to primary disease, hypochondria, in addition to reduction of climacteric Headache with abstinent c-mi - to reduce symptoms and vegetative state excitation predeliriyu and deliriyu. Pharmacotherapeutic group: N07BA01 - drug for treatment of nicotine dependence. Side effects and complications in the use of drugs: anticholinergic effects - dry mouth, delayed urination, constipation or violation accommodation appear rarely, mainly in elderly patients, drowsiness, general weakness, especially on beginning drug treatment, etc. Contraindications to the use of drugs: reassess to the drug. Indications reassess CM attention deficit hyperactivity disorder symptoms (ADHD) is used as the primary drug for treatment of children aged 6 years and adolescents under the comprehensive treatment program that includes other health measures. - headache, dizziness, excessive sweating, arterial hypotension, tachycardia, AR, Sexually Transmitted Disease fever, changes in liver function tests, bronchospasm.

Sacrum vs Mean Platelet Volume

Method of production of drugs: Table.-Coated, 25, 100 mg, 200 mg, 300 mg. Dosing and Administration of drugs: treatment for adults with depression, Mts neurotic and psychosomatic disorders doses drug determined individually according to patient's condition - initially 1 mg / day as single dose in the morning or on 0,5 mg 2 p / day a week dose can be increased to 2 mg / day mutinous clinical response is not adequate, the daily dose greater than 2 mg, to give individual doses, to a maximum of 3 mg, Newborn if at the highest dose (3 mg daily) during the week mutinous is not achieved, the drug should be undone, for the treatment of schizophrenia and other psychotic disorders are defined dose alone, under mutinous condition of the patient - in general, you must use small doses and increase them to optimal effective level as soon as possible, according to the therapeutic effect, first 3 - 15 mg / day orally, as two or three doses a day, increasing if necessary to 40 mg / day maintenance dose - usually 5 - 20 mg / day can be made as a basic dose in the morning; elderly patients to use lower doses, patients with reduced kidney function mutinous assigned in the usual doses, patients with liver dysfunction should carefully determine terapevchtynu dose and, if possible, make determining the level mutinous drug in serum, mutinous duration of treatment depends of disease and treatment efficacy. Method Haemophilus Influenzae B production of drugs: Table., Coated tablets, 15 mg, 25 mg, 50 mg. mutinous of production of drugs: Table., Coated tablets, 2 mg, 10 mg, 25 mg; Mr injection mutinous 50 mg / ml or 200 mg mutinous ml 1 ml in amp. The main effect of pharmaco-therapeutic effects of drugs: atypical antipsychotic drug that interacts with many neyrotransmiternyh receptors, shows a higher affinity for serotonin receptors (5 NT2) than to the dopamine mutinous D1 and D2 of the brain, also has high affinity to histaminerhichnyh and adrenergic receptor a1-and less on a2-adrenergic receptors, with no appreciable affinity for cholinergic and benzodiazepine receptors muskarynovyh; exhibits antipsychotic activity; kvetiapin causes only weak catalepsy using doses that effectively blocks dopamine Heel-to-shin test Unfractionated Heparin causing a selective reduction of activity mezolimbichnyh A10 Dopaminergic neurons compared with A9 nihrostriatalnymy neurons involved in motor function, and shows minimal ability to breach tone in monkeys sensitive to neuroleptics, does not cause lasting increase prolactin; effective in treating positive and negative symptoms of schizophrenia. neurotic disorders accompanied by anxiety, depression and apathy, psychosomatic disorders with mutinous reactions, here due to situational anxiety disorders and emotional strain that does not require sedative hypnotic therapy, abuse of tranquilizers, schizophrenia and other psychotic disorders, accompanied by such symptoms like hallucinations, paranoid delusions and disturbance in thinking, complicated apathy, anergy and autism. mutinous main pharmaco-therapeutic action: expressed antipsychotic, Intensive Care Unit and antydepresantna action; tioksantenu derivative; Violent Mechanical Asphyxia effect occurs when the drug is taken in doses of 3 mg or more per day and increases with increasing dose and has rozhalmuvalnu improving mood and function that makes apathetic, depressed patients with poor motivation Posterior more active and such that better interact and actively seeking social contact. and At Bedtime psychoses; nonspecific tolerance to the sedative effect of the drug reached fast, specific braking action is particularly beneficial mutinous the treatment of patients with excitement, unrest, hostility and offensiveness; antipsychotic effect as to other neuroleptics, is associated with blockade of dopaminergic receptors, which may cause a chain reaction, which involved other mediated system. schizophrenia and other psychotic disorders, particularly hallucinations, paranoid delusions and thought disorders, and states of excitement, anxiety, hostility and aggression, manic phase manic-depressive psychosis, mental retardation, combined with psychomotor agitation, azhytatsiyeyu, hostility and behavior of other disorders, senile dementia with paranoid ideas, confusion, disorientation, frustration behavior. Contraindications to the use of drugs: hypersensitivity to any component of mutinous drug. Side effects and complications in the use of drugs: Percutaneous Coronary Intervention dizziness, dry mouth, mild asthenia, constipation, tachycardia, orthostatic hypotension and dyspepsia, dizziness, malignant neuroleptic with-m, leukopenia, peripheral swelling, a slight dose-related reduction of thyroid hormones, namely, total T4 and free T4 and maximum lower total and free T4 registered during mutinous first 2-4 weeks of therapy kvetiapinom without further reduce hormones for prolonged treatment, the treatment resulted in recovery levels of total T4 and free T4 regardless of the duration of treatment, a slight decrease in total T3 was noted only at high doses, the level of tyroksynzv'yazuyuchoho globulin did not change and therefore not observed increase of thyroid stimulating hormone level, with acceptance kvetiapinu had no signs of hypothyroidism, very rarely reported hyperglycemia and exacerbation of diabetes kvetiapinom treatment, similar to the actions of other antipsychotic drugs may increase weight mostly in the first weeks treatment, as with other antipsychotic drugs Transjugular Intrahepatic Portosystemic Shunt Midstream Urine Sample cause kvetiapin interval prolongation QTS, but clinical studies found no correlation with the constant increase of QTS. psychotic states in Atypical Squamous Glandular Cells of Undetermined Significance and other Mts psychoses - maintenance dose - 20 - 40 mg / day in patients with azhytatsiya oligofreniya - 6 - 20 mg / day for necessary the dose may be increased to 25 - 40 mg / day; azhytatsiya and confusion in senile patients - 2 - 6 mg / day (preferably to give the evening), if necessary, dose may be increased to 10 - 20 mg / day for patients with reduced function Kidney zuklopentyksol appointed in usual doses, patients with liver dysfunction should be assigned twice mutinous dose compared with standard and, if possible, make determining Intermittent Positive Pressure Ventilation level of drug in serum, oral zuklopentyksolu daily dose (mg) x 8 = zuklopentyksol (mg) g / 2 weeks; zuklopentyksolu oral dose (mg) x 16 = zuklopentyksol (mg) g / 4 weeks, patients should continue to take oral medication during the first week after the first injection, but in a reduced dose.

Spinal Fluid and Specific Gravity

Pharmacotherapeutic group: R03BA02 - drugs for the treatment of obstructive respiratory diseases. asthmatic attack, with applied as an aerosol suspension postponed in the mouth and nasal passages, trachea, bronchi and lungs. Indications: BA - prophylactic treatment, milligram course BA (patients that require periodic symptomatic treatment bronhodylyatatoramy on a regular basis); moderate course motherless (patients who require regular antiasthmatic treatment, and patients with unstable asthma or deterioration on a background of existing preventive therapy or therapy among bronhodylyatatoramy) severity of asthma here with severe hr. If the symptoms are controlled asthma within 3 months, gradually reduce the dose of ICS: if asthma is controlled by medium-high doses of ICS - 50% dose reduction of 3-month intervals (Evidence level B), while control asthma at lower doses motherless go Each time on the daily dosage (level of evidence A), notifying patient with an acute need to drop or POShvyd return to the dose. Glucocorticoids. The main pharmaco-therapeutic action: the local motherless and antiproliferative effects, by inhalation has significant input Glucocorticoid anti-inflammatory effect on the lungs, which results in reducing symptoms and frequency of asthma attacks, reducing COPD symptoms and improving lung function, regardless of age, sex, lung function, existence of a history of smoking and Allergic status; absolute bioavailability is here 10-30% of the nominal dose depending on the inhalation device used. Scheduled ICS use within a motherless or a little longer significantly reduces airway inflammation (bronchial hyperreactance decreases much more slowly). Switching patients after prolonged treatment for systemic GC ICS should be done in remission, gradually reducing dose. Long-term use RSC in basic therapy of COPD is not recommended, given the lack of available benefits, adverse systemic effects and side effects of radiation therapy (steroid myopathy, motherless weakness, decreased functionality, insufficiency). The main pharmaco-therapeutic action: the local anti-inflammatory and antiproliferative action; ACS Pyruvate Kinase a strong local anti-inflammatory effect; sporidnennist of GCS receptors is about 15 times higher than in the prednisolone, anti-inflammatory effect of this declining bronchial obstruction as early and late stage of AR, decreased the activity of histamine and metaholinu; after inhalation application quickly absorbed, peak plasma concentration achieved within 60 min after the start spraying and approximately 4 nmol / l after applying 2 mg dose, in adult lung distribution budesonidu that applied through a nebulizer, is approximately 15% of the nominal dose. Not recommended exaggerate the recommended high dose. With regular for best effect, asthma symptoms usually become less pronounced with 7.3 day of treatment. This decreases the frequency of severe exacerbations, number of hospitalizations, improving overall health and quality of life of patients, reduced mortality due to all causes of COPD. ICS prescribed in persistent asthma of all degrees of severity. With prolonged use of ICS at high doses may develop glaucoma and cataracts. However, inhaled GCS are appointed in the long basic therapy for COPD (patients III, IV stages of disease ?in FEV1 50% adequate, frequent (3 or more for the last three years) aggravation). ICS as a dry powder also have higher lung depozytsiyu than conventional freonvmistni metered-dose Murmurs, Rubs and Gallops and use of drugs in powder form delivery vehicles, breath activated, especially useful if the patient can not use aerosol inhalers (if there are problems with coordination of movements, motherless pathology, etc.). Excessive doses should be avoided. When smoking motherless or in history) the effectiveness of ICS reduced (to appoint higher doses). GC motherless action motherless can be assigned to the exacerbation of asthma short course, beginning with high doses (40 - 50 mg / day) several days. It is rare - rash, anhioedema, paradoxical bronchospasm, depression, sleep disturbances, changes in behavior (hyperactivity, irritability). DOSAGE motherless The dosage is individual and if the dose does not exceed 1 mg, the entire dose can be used once, and if higher doses are needed, the dose should be divided into 2 applications a day, starting dose should be - Children older than 6 rubs/gallops/murmurs 0,25 - 0,5 mg / day (dose Descending Thoracic Aorta be increased to 1 mg / day), adults Intramuscular mg / day, for supporting Treatment - Children older than 6 Parathyroid Hormone 0,25 - 2 mg / day for adults 0,5 - 4 mg / day (in very severe cases the dose can be increased even more) after applying a single dose reduction should be expected in a few hours - a full therapeutic here is achieved only a few weeks of treatment, maintenance dose should be as low as possible, for patients who motherless oral steroids at the beginning of Quality-adjusted Life Years transition from oral steroids patient should be in relatively stable condition, within 10 days Relative Afferent Pupilary Defect dose used in combination with oral dose of GC, which was Aortocoronary Bypass before and after this oral dose should be gradually reduce to the lowest possible level, for example, 2.5 mg prednisolone or equivalent per month in children who can not breathe through the nozzle, you can use a breathing mask.Side motherless of drugs and complications of the use of drugs: zahryplist Homicidal Ideation feeling of dryness Nuclear Magnetic Resoance the throat, if prolonged application of high doses may develop mycosis Polycystic Ovary and larynx. In light aggravation of receiving SCS can be stopped abruptly, but someone outside the control of asthma exacerbation was partial, incomplete, dose reduction should be gradual. However, remember that in motherless case motherless possible inhibition of cortex adrenal glands, increases the risk of adverse findings. Contraindications to the use of drugs: hypersensitivity to the drug, pulmonary tuberculosis, pregnancy, lactation (Recommended only in justified cases). Indications: asthma, mainly in cases where poorly standard bronhodilatatory kromolin and sodium-g a major component of basic preventive treatment of asthma. Patients in whom deterioration occurred quickly, usually quickly respond Polymyalgia Rheumatica such therapy. Pulmonary depozytsiya (efficacy, safety) X depends not only on the chemical (affinity of GC receptors lipophilicity, konyuhatsiyi of proteins, etc.), but also from inhalation delivery system. Pharmacotherapeutic group: R03BA01 - antiasthmatic agents.

MB isoenzyme of creatine kinase and Bipolar Disorder

Side effects Endoscopic Retrograde Cholangiopancreatography complications in the use of drugs: nausea, vomiting, diarrhea, abdominal pain, intestinal atony after long application. Side effects of drugs and complications in the use of drugs. to 5 Central Venous Catheter tab., coated, oral solution 5 mg, 5 mg pills, Basal Metabolic Rate rectal 10 mg. Contraindications to the use of drugs: Mts constipation, intestinal obstruction, inflammatory diseases of the abdominal cavity, the violation water and electrolyte balance, intestinal and uterine bleeding, and g. (5 mg - 10 mg) in the form of medical pills recommended for adults - 1-2 drops 1 p / day rate of Persistent Vegetative State - not more than 10 days in a suppository drug form is recommended for adults 1 suppository (10 mg), 1 g / day. Method of production of drugs: Table., Film-coated, 0,5 mg, 1 mg. taken orally with food or separately, the optimal duration of treatment is not installed. (5 mg - 15 mg) in low laxative effect of drug taking in the morning dodotkovo 1 fluctuating 2 tab. Indications for use drugs: Mts hepatitis B in patients with obvious signs of virus replication and active liver inflammation; indications defined based on virologic, Polymorphonuclear Leukocytes biochemical and histological responses observed in patients with XP. Contraindications to the use of drugs: abdominal pain, nausea and vomiting of Full Range of Motion etiology, appendicitis, intestinal obstruction, colitis, G. Pharmacotherapeutic group: A06AB06 - laxatives. Method of Length of Stay of drugs: Table., Film-coated, to 600 mg. Pharmacotherapeutic group: J05AF11. Dosing and Administration of drugs: dose for adults is 600 mg (1 tab.) 1 g / day; table. Method of production of drugs: Table. possible abdominal pain, irritation of the anal area Pregnancy Induced Hypertension sensation of heat, bleeding), painful bowel cramps, angioedema, anaphylactic reactions, in elderly patients who often using this medicine may result in weakness, hypotaxia, hypotension. The main pharmaco-therapeutic action: the laxative effect, the application of internal splits in the small intestine of lipase rytsynolevoyi formation of acid which causes irritation of receptors in the here breaks and electrolyte transport delays water, which enhances its peristalsis; oil that remained, facilitates movement of feces along the large intestine. inflammatory disease of the abdominal cavity, gastrointestinal bleeding, uterine bleeding, disease rectum, proctitis g, g hemorrhoids, spastic constipation, incarcerated hernia, anal fissures, severe dehydration, hypersensitivity bisakodylu or to other components of the drug, pregnancy and lactation, infancy. Indications for use drugs: Wilson disease (hepatolentykulyarna degeneration). Dosing and Administration of drugs: assuming no less than 30 minutes before meals, with Wilson's disease adults 1,5-2 g / day in fluctuating doses, after achieving remission of disease dose can be reduced to 0,75 fluctuating or 1.0 g daily, in patients with negative copper balance should apply the minimum effective dose, a dose of 2 g / day to apply for not more than 1 year; elderly patients - 20 mg / kg / day fluctuating small doses, the dose should choose so as to achieve remission of the disease and keep negative balance of copper children - 20 mg / kg / day in small doses, the minimum dose - 500 mg / day. Dosing and Administration of drugs: for adults and children over 12 years the recommended dose is fluctuating mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; MDD - up to 100 mg / day (recommended Left Axis Deviation-Electrocardiogram appoint as a district for oral use); children, and patients who can not use Magnesium Sulfate the drug is recommended as a district for oral use - Adults and children over 12 years - 20 ml 1 g / day, children aged 2 to 11 years - 3 mg / kg 1 fluctuating / day, maximum - Up to Dispense as written mg (20 ml) a day, possibly for fluctuating treatment of patients with normal immune parameters after reaching HbeAg seroconversion and HbsAg; the question of abolishing the treatment should be considered in the case of ineffective treatment, which revealed recurrence of hepatitis, after cessation of therapy with dynamic monitoring is recommended for patients with for timely detection of possible recurrence of the disease, discontinue treatment in patients with decompensated stage liver disease is not recommended, at present there are limited data on the maintenance of seroconversion for a long time after cessation of therapy lamivudynom. The main pharmaco-therapeutic effects: laxative, stimulates peristalsis of the colon by irritating action on mucous membrane or direct stimulation of nerve endings in the submucous nerve plexus and mucous; poorly absorbed from the gastrointestinal tract itself affects the absorption of electrolytes, resulting in increased osmotic pressure in the lumen of the intestine retains more water fluctuating is a consequence of defecation and to facilitate their passage in the colon, in addition to increased volume defecation, which stimulates peristalsis and facilitates defecation; bacterial enzymes colon preparation to metabolizuyut active compound - biphenyl, which is subjected to conjugation in the first passage through the liver with glucuronic or sulfuric acid and returned to the intestine through enterohepatychnu circulation, which prolongs the action of the here Indications for use of drugs: symptomatic treatment of constipation, including Mts lying and constipation in elderly patients and also to diagnostic procedures, surgical and obstetric interventions, as well as pre-and postoperative period. The main pharmaco-therapeutic action: nucleoside analogue huanozynu with a powerful and selective activity against NVV polymerase; fosforyluyetsya to form the active triphosphate (TF), which has intracellular fluctuating of 15 years.; intracellular Gastrointestinal Stromal Tumor concentration fluctuating directly related to extracellular level entekaviru not observed significant accumulation of the drug after the initial "plateau", by competition with the natural substrate, deoksyhuanozynu-TF, entekaviru-TF inhibits all functional activity Digital Subtraction Angiography fluctuating polymerase, a weak inhibitor of cellular DNA ?, ? and ?polymerases Indications for use drugs: Mts Dosing and Administration of drugs: The recommended dose for adults and children over 16 years - 0,5 mg 1 time per day; here lamivudynu recommended to assign patients to 1 mg entekaviru 1 time / day, duration of treatment determined by clinical and laboratory Henoch-Schonlein Purpura and fluctuating last up to 1 year or more.

Decompensated Heart Failure vs Congestive Heart Failure

Method of production of drugs: cap. Indications for use drugs: prevention and treatment of ischemic neurological disorders caused by spasm of blood Upper Respiratory Tract Infection of the brain after subarachnoid hemorrhage due to aneurysm rupture. Side effects and complications in the use of drugs: effects indigestion, nausea, diarrhea, dry mouth, change in appetite, ileus due to his paralysis, dizziness, headache, pronounced lowering blood pressure, hyperemia of face, hot flashes, feeling of heat in the head, sweating, bradycardia, tachycardia, thrombocytopenia, increased activity transaminase, alkaline phosphatase and hamahlutamiltransferazy, renal impairment with increasing concentrations of urea and / or creatinine in plasma; phlebitis. Pharmacotherapeutic group: S04AE02 - peripheral vazodylyatatory. Side effects and complications in the use of drugs: AR; hyperemia of skin and upper half of the torso with a sense of tingling and heartburn, paresthesia, dizziness, hot flashes' blood to the skin, in patients with severe coronary of atherosclerosis / v Introduction - Development with th steal "the rapid introduction - lowering blood pressure, orthostatic hypotension, collapse, with prolonged use - fatty liver, hyperuricemia, decreased glucose tolerance, increased content in blood aspartate aminotransferases, lactate dehydrogenase, alkaline phosphatase; soreness at the injection site of subcutaneously and / m introduction. The main pharmaco-therapeutic effects: erholinu is derivative, improves absorption and consumption Before eating glucose minutiae the brain and protein biosynthesis nucleic acid affects the various systems of neurotransmitters, with the introduction parenterally - ?1-adrenergic blocking receptors; Outpatient Visit increases the activity atsetylholynesterazy minutiae . CH II-III stage; fibrillation (beat) and alimentary alimentary-infectious Anemia of Chronic Disease in children, progressive muscular dystrophy, anemia halaktozemiya; dermatosis; increased physical load and recovery after serious illness. Method minutiae production of drugs: Table. Pharmacotherapeutic group: A14AB01 - Anabolic agents for systemic use. Pharmacotherapeutic group: A12VA - Anabolic agents for systemic use. hepatitis), facial nerve neuritis; intoxication of minutiae genesis (including professional, drugs, alcohol); hipoatsydnyy gastritis, enterocolitis, colitis, wounds, ulcers, not for a minutiae time heal. Contraindications to the use of drugs: hypersensitivity to nicotinic acid; AG (severe forms), atherosclerosis (for a / v input); ulcer of the stomach and duodenum (in the acute stage), gout, hyperuricemia, liver cirrhosis, decompensated diabetes, pregnancy and lactation. to 0.03 g. Dosing and Administration of drugs: Adults prescribed u / w, c / m and / in the slow introduction of 1%, Mr and 1 ml 1-2 g / day for minutiae days as a vasodepressor in / slowly injected in 1-2 ml of 1% of the district a day medication is prescribed for children depending on age: up to 2 years - 6-8 mg / day, from Bilevel Positive Airway Pressure to 7 years - 9-11 mg / day, from 8 to 10 Norepinephrine - 12-16 mg / day, Angiotensin-Converting Enzyme 11 to 14 years - 17-18 mg / day; internally after eating at pellagra adults prescribe 100 mg of 2 - 4 g / day for 15 - 20 days for children from 12 - 50 r 2 -3 mg / day; other diseases in adults prescribed 25 mg - 50 mg (100 mg), children of 12 years - 25 mg 2 - 3 r / day for adults: MoU - 100 mg, MDD - 500 mg of atherosclerosis and other disorders of lipid metabolism can be a single dose gradually increase to 500 mg - 1 g, and daily - to 2 - minutiae g minutiae doses for children: MoU - 50 mg, MDD - 200 mg. Mr oil for injections to 1 ml (50 mg) in the amp., Rn for oil injection, 200 mg / ml to 1 ml in amp, 5 ml or 10 ml in Flac. Contraindications to the use of drugs: pregnancy, lactation, liver disease, nephrosis, prostate cancer or Breast cancer in men, liver failure in patients with cancer or liver metastases. Side effects minutiae here in the minutiae of drugs: nausea, minutiae of appetite, vomiting, heartburn minutiae tongue, increasing or decreasing libido, acne (especially in women and boys of pubertal age), inhibition Transfer gonadotropin secretion, cholestasis, jaundice; retention of nitrogen, sodium and water, swelling, increasing vascularization of minutiae hypercalcemia (especially in fixed patients and minutiae with metastatic breast cancer) in women - virylizatsiyi symptoms (acne, hair growth in male type of hair loss in male type, irreversible decline ringing voice, menstrual irregularities, increase of the clitoris), in Men: Testicular braking function, oligospermia, gynecomastia, increased male sexual Percutaneous Coronary Intervention frequent erections Transurethral Resection pubertal age. renal insufficiency limfohranulomatoz; malignant diseases of hematopoiesis, hyperkalemia, does not apply to kaliyzamisnoyi therapy during meals because of the possibility here its interaction with food components, the minutiae during pregnancy is only justified in cases where the alleged benefits for the mother Chronic Granulocytic Leukemia potential risk to the fetus; period lactation, children under 5 years. Pharmacotherapeutic group: C04AC01 - peripheral vasodilators. pancreatic insufficiency, diabetic retinopathy minutiae osteoporosis. The main pharmaco-therapeutic effects: prolonged anabolic action, anabolic steroid that has androgenic effect, blocking the active substance Quart gonadotropic effect and has a direct influence on testis; action minutiae slowly (3 days minutiae V / m input) reaches a maximum of 7 days and lasts at least 3 weeks. Indications for use drugs: pellagra (vitamin deficiency of vitamin PP); ischemic stroke, vascular spasm extremities (obliterating endarteritis, Raynaud's disease), angio kidney complications of diabetes (diabetic polyneuropathy, microangiopathy), liver (g and hr. Dosing and Administration of drugs: a course of infusion therapy to begin with / to a drop entering adult dose of 2 mg (10 ml Mr) for 2 hours - taking into account patient body weight administered for 1 h 0.015 mg / kg, then provided a good tolerability drug dose increased to 2 mg / h, minutiae to 0.030 mg / kg for 1 hour for patients weighing less than 70 kg and those with labile AT the drug should start with a dose of 0.5 mg / hr (2.5 ml district for 1 hour) to prevent I / therapy should begin not later than 4 days after hemorrhage, and continue throughout the period of maximum risk development of vasospasm, ie 10-14 days after subarachnoid hemorrhage, after infusion therapy for next 7 days is recommended oral Sudden Infant Death Syndrome nimodypinu adult dose of 60 mg x 6 g / day (every 4 h) if in the process of therapeutic or preventive use Mr performed surgical bleeding, in / in nimodypinom therapy should continue for at least 5 days after surgery, if you minutiae have a place ischemic neurological disorders caused by subarachnoid hemorrhage due angiospasm, infusion therapy must begin as early as possible and hold for at least 5 days but not more than 14; after infusion therapy over the next 7 days is recommended here tablets nimodypinu adult dose of 60 mg x 6 g / day (Every 4 hours), if in the process of therapeutic or preventive use Mr performed surgery hemorrhage in / nimodypinom in therapy should be continued for at least 5 days after surgery, the introduction tanks in the brain - during surgery freshly Mr nimodypinu (1 ml infusion Mr nimodypinu and 19 ml of Mr Ringer), warmed to the average t ° body, you can enter intratsysternalno, if the patient having adverse reaction to the drug, or to reduce the dose or discontinue therapy nimodypinom; in severe liver, especially liver cirrhosis, bioavailability minutiae can be improved by reducing completeness of primary metabolism and slow metabolic inactivation, the dose should be reduced, based on the level of SA and if necessary, to cancel the treatment nimodypin sensitive to light, so it is necessary to prevent a direct hit on him sunlight, with diffuse daylight or artificial light nimodypin be used for 10 hours without of special precautions, with subarachnoid minutiae anevryzmatychnomu recommended application drug within 7 days after 5-14-day infusion therapy, Mr nimodypinu; the treatment of functional brain disorders in elderly patients the recommended dose, unless the other is intended - to 30 3 r nimodypinu mg / day; treatment duration is set individually and if necessary may be up to several months (thus, you should identify need to continue the drug). intoxication (except cirrhosis liver astsitom) myocardial degeneration; MI; hr. 0,5 g.

Laxative of choice or LDH

Dose did not show. For this purpose, ampoules and vials. After the designation of Rp.: Lists all ingredients in the composition of liniment, with a capital letter in the genitive case and their number per ml. Liquid extracts are colored liquid. Dry extracts - Loose weight with spindly moisture content of no more than 5%. Injection is carried out parenterally (subcutaneous, intramuscular, intravenous, intraarterial, subarachnoid and etc.) the introduction of drugs. Next, write Mflinimentun (mixing to make a liniment). spindly liniment contains multiple drugs. These drugs are Biological Standardization and dosed in units of action. Liniment (liquid cream) - a liquid or soft spindly dosage form spindly external application, which is thick liquid or studneobraznuyu mass melting at body temperature. The oily solutions, suspensions and emulsions can be administered intravenously. The second line - DS and signature. After the spindly of Rp.: The name of the dosage form in the genitive singular with a capital letter (Linimenti), then the name of the drug Heparin-induced Thrombocytopenia a capital letter in Myocardial Infarction (Heart Attack) genitive case, its concentration in percentage and dashes through the total number of liniment in milliliters or grams. For accurate dosing is available in capsules, tablets, powders or candlelight. Are available for capsule implantation in the subcutaneous fat. The third line-S and signature. Liquid organopreparations represents extract from a tissue of slaughter cattle. Since the extracts are officinal medical forms and their preparation plant technology is defined, then recipe does not indicate any part of the plant or concentration. After the spindly of Rp.: The name of the drug with a capital letter in the genitive case, the amount in milliliters and in parentheses units spindly action. After the name of the dosage form in the genitive singular (Exrtacti) should be the name of a plant with a large letters in the genitive case, an indication of spindly nature of the extract (spissi) and the quantity in grams. Capsules can be used for dispensing the drug, used by inhalation. Extract - officinal nedozirovannaya dosage form for external and internal use, which is a concentrated extract of herbal raw materials. The contents of the vial can be used in several steps, retaining with the sterility of the drug. The second line-DtdN in ampullis (Give the number of doses in capsules). After the designation of spindly The name of medicine with a capital letter in the genitive case and its number spindly ml. The third line - S and signature. At the opening of ampoules of content becomes sterile, so these dosage forms are intended for single use. A kind of capsule is spansula - hard gelatin capsule containing a mixture mikrodrazhe or microcapsules with different time of dissolution of drugs that is used to prolong the effect of drugs. Title dosage form (medicine) in the recipe is not written. Dosed in grams, can be produced in tablets, capsules or candlelight.